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Abstract 
 
South Africa, like many other developing nations, is faced with the challenge of mobilising resources 
to fight the HIV/AIDS pandemic. There is a huge budget gap between the ideal and actual funding 
provided to achieve universal access to highly active antiretroviral therapy (HAART), which leads to 
the inevitable rationing of HAART. Although healthcare spending has been increasing in South 
Africa, new demands are being placed on the HAART roll out programmes. This is particularly due to 
the emergence of HIV drug resistance (HIVDR). Because non-adherence to HAART is strongly 
linked to drug resistance, this is a major threat to any successful HAART programme. In the face of 
restricted resources, this research report looks at some of the ethical and economic implications of 
non-adherence to HAART. I suggest that there is merit in considering that HAART be restricted only 
to adherent patients. 
 
